Prevention of transplantable tumors by adoptive transfer of spleen cells from immunized rats.
Fischer 344 rats were specifically hyperimmunized with allogeneic, nonvirus-producing [Kirsten murine sarcoma virus (KiMSV)] or syngeneic, virus-producing [KiMSV (Rasheed)] rat tumors. Spleen cells taken from these rats adoptively transferred protection against a 100 to 1,000 X rat tumor dose50 cell challenge with several different transplantable rat tumors. Protection was obtained with spleen cells after removal of adherent cells and macrophages but not peritoneal cells. The spleen cells were not directly cytotoxic but required more than 3 days residence in the recipient before protecting the recipient against challenge. No protection against tumor cell challenge was observed when spleen cells were lethally x-ray irradiated before injection into nontreated rats. Spleen cells taken from rats immunized with normal histocompatibility antigens did not protect in this test system.
D000818:Animals; D002448:Cell Adhesion; D002471:Cell Transformation, Neoplastic; D005260:Female; D006649:Histocompatibility Antigens / Q000276:immunology; D007114:Immunization; D007116:Immunization, Passive; D007942:Leukemia, Experimental / Q000517:prevention & control*; D008264:Macrophages / Q000276:immunology; D008297:Male; D009368:Neoplasm Transplantation; D051381:Rats; D011916:Rats, Inbred F344; D011920:Rats, Inbred WF; D012513:Sarcoma, Experimental / Q000517:prevention & control*; D013154:Spleen / Q000276:immunology; D013997:Time Factors
D006649:Histocompatibility Antigens